These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29234540)

  • 21. Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study.
    Bolat D; Gunlusoy B; Degirmenci T; Ceylan Y; Polat S; Aydin E; Aydogdu O; Kozacioglu Z
    Arch Esp Urol; 2016 Jun; 69(5):225-33. PubMed ID: 27291558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial.
    Del Rosso A; Pace G; Masciovecchio S; Saldutto P; Galatioto GP; Vicentini C
    Int J Urol; 2013 Apr; 20(4):399-403. PubMed ID: 23003110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer.
    Cheng B; Qiu X; Li H; Yang G
    Ther Clin Risk Manag; 2017; 13():983-988. PubMed ID: 28860782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NBI - plasma vaporization hybrid approach in bladder cancer endoscopic management.
    Stănescu F; Geavlete B; Georgescu D; Jecu M; Moldoveanu C; Adou L; Bulai C; Ene C; Geavlete P
    J Med Life; 2014 Jun; 7(2):155-9. PubMed ID: 25408719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials.
    Xie K; Cao D; Wei Q; Ren Z; Li J; Li Y; Fu M
    World J Urol; 2021 Apr; 39(4):1177-1186. PubMed ID: 32462303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transurethral resection of bladder tumour (TURBT).
    Kim LHC; Patel MI
    Transl Androl Urol; 2020 Dec; 9(6):3056-3072. PubMed ID: 33457279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thulium Laser Endoscopic En Bloc Enucleation of Nonmuscle-Invasive Bladder Cancer.
    Migliari R; Buffardi A; Ghabin H
    J Endourol; 2015 Nov; 29(11):1258-62. PubMed ID: 26102556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer.
    Ozer K; Horsanali MO; Gorgel SN; Ozbek E
    Cent European J Urol; 2015; 68(3):284-8. PubMed ID: 26568867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
    Gondran-Tellier B; Abdallah R; Sichez PC; Akiki A; Toledano H; Gaillet S; Delaporte V; Karsenty G; Bastide C; Daniel L; Garcia S; Rossi D; Lechevallier E; Boissier R; Baboudjian M
    Prog Urol; 2021 May; 31(6):316-323. PubMed ID: 33663939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
    Gakis G; Karl A; Bertz S; Burger M; Fritsche HM; Hartmann A; Jokisch F; Kempkensteffen C; Miller K; Mundhenk J; Schneevoigt BS; Schubert T; Schwentner C; Wullich B; Stenzl A
    BJU Int; 2020 Oct; 126(4):509-519. PubMed ID: 32578332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis of the Efficacy of Transurethral Bipolar Plasma Needle Electrode and Ring Electrode in the Treatment of Non-Muscle-Invasive Bladder Cancer.
    Zheng P; Zhang J; Zhu Y; Guan X; Quan J; Li Q; Yi F
    Comput Intell Neurosci; 2022; 2022():6044676. PubMed ID: 35602629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.
    Kang W; Cui Z; Chen Q; Zhang D; Zhang H; Jin X
    Oncotarget; 2017 Apr; 8(14):23880-23890. PubMed ID: 27823975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.
    Xishuang S; Deyong Y; Xiangyu C; Tao J; Quanlin L; Hongwei G; Jibin Y; Dongjun W; Zhongzhou H; Jianbo W; Lina W; Lin Y
    J Endourol; 2010 Jan; 24(1):69-73. PubMed ID: 19954353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis.
    Cui Y; Chen H; Liu L; Chen J; Qi L; Zu X
    J Laparoendosc Adv Surg Tech A; 2016 Mar; 26(3):196-202. PubMed ID: 26799841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.